SEC Form 4 · accession 0001209191-17-044262
Dova Pharmaceuticals Inc. · DOVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Steven M. Goldman
Director
Period of report
Jul 5, 2017
Accepted (ET)
Jul 7, 2017 · 6:45 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001685071
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 5, 2017 | P | 42,000 | $17.00 | A | 42,000 | D | |
| Common Stock | Jul 5, 2017 | P | 30,000 | $19.25 | A | 72,000 | D |
Table II — derivative securities
No Table II lines on this filing.